| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/06/2009 | CA2340921C Use of taxanes to treat brain cancer |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/01/2009 | US20090007280 Ange gene in atopy |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005441 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 01/01/2009 | US20090005412 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/01/2009 | US20090005357 Pharmacological Treatment for Sleep Apnea |
| 01/01/2009 | US20090005327 Essential n-3 fatty acids in cardiac in sufficiency and heart failure therapy |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090004238 Implantation of encapsulated biological materials for treating diseases |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004200 Combination treatment of pancreatic cancer |
| 01/01/2009 | US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 01/01/2009 | US20090004168 Health Enhancement System |
| 01/01/2009 | US20090004159 Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells |
| 01/01/2009 | US20090004158 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/01/2009 | US20090004109 Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins |
| 12/31/2008 | WO2009003185A1 Regulatory t cells in adipose tissue |
| 12/31/2008 | WO2009002970A1 Compositions comprising tryptophan hydroxylase inhibitors |
| 12/31/2008 | WO2009002829A2 Tableted compositions containing atazanavir |
| 12/31/2008 | WO2009002826A2 Tableted compositions containing atazanavir |
| 12/31/2008 | WO2009002823A2 Tableted compositions containing atazanavir |
| 12/31/2008 | WO2009002821A2 Tableted compositions containing atazanavir |
| 12/31/2008 | WO2009002652A2 Use of surfactants for treating mycobacterial infections |
| 12/31/2008 | WO2009001899A1 Aqueous composition |
| 12/31/2008 | WO2009001857A1 Composition for ophthalmic disease associated with hypoxia or ischemia |
| 12/31/2008 | WO2009001661A1 Medicinal agent for prevention or treatment of alzheimer's disease |
| 12/31/2008 | WO2009001040A2 Treatment of depression |
| 12/31/2008 | WO2009000926A1 Combinations of sap depleting agents and anti-sap antibodies |
| 12/31/2008 | WO2009000843A2 Treatment of heart failure in non-human animal mammals by an aldosterone antagonist |
| 12/31/2008 | WO2009000558A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | WO2009000551A1 Use of a synergistic composition as a therapeutic agent or disinfectant |
| 12/31/2008 | WO2009000038A1 Combination methods and compositions for treatment of neuropathic pain |
| 12/31/2008 | WO2008113862A3 Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 12/31/2008 | WO2008089388A3 Treatment of cancers having resistance to chemotherapeutic agents |
| 12/31/2008 | WO2007131689A3 Pharmaceutical combinations comprising a mtor inhibitor and a raf kinase inhibitor |
| 12/31/2008 | EP2009021A1 DNA molecules encoding ligand gated ion channels from dermacentor variabilis |
| 12/31/2008 | EP2009000A1 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 12/31/2008 | EP2008658A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | EP2008650A2 Solid oral composition comprising a S 1 P receptor agonist and a sugar alcohol |
| 12/31/2008 | EP2007429A1 Oral formulation with beneficial cardiovascular effects, comprising berberine |
| 12/31/2008 | EP2007428A2 Method for using boc/cdo to modulate hedgehog signaling |
| 12/31/2008 | EP2007427A2 Improved vaccines comprising multimeric hsp60 peptide carriers |
| 12/31/2008 | EP2007400A1 New medicines for treatments against retroviruses |
| 12/31/2008 | EP2007394A1 Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses |
| 12/31/2008 | EP2007391A2 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor |
| 12/31/2008 | EP2007373A2 Inhibition of alpha-synuclein toxicity |
| 12/31/2008 | EP2007227A2 Lycopene for the treatment of metabolic dysfunction |
| 12/31/2008 | EP1896489B1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 12/31/2008 | EP1765404B1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 12/31/2008 | EP1684722B1 Medicamentously targeted local lipolysis |
| 12/31/2008 | EP1509600B1 Plant thymidine kinases and their use |
| 12/31/2008 | EP1494685B1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker |
| 12/31/2008 | EP1465610B1 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation |
| 12/31/2008 | EP1437137B1 Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
| 12/31/2008 | EP1413332B1 Use of 2,5-dihydroxybenzenesulphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction |
| 12/31/2008 | EP1402788B1 Body temperature-raising agent of amino acids for eating or drinking and for medical use |
| 12/31/2008 | EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 12/31/2008 | EP1296672B1 Stable pharmaceutical product and formulation |
| 12/31/2008 | EP1294879B1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 12/31/2008 | EP1283735B1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 12/31/2008 | EP1268525B1 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 12/31/2008 | EP1266009B1 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 12/31/2008 | EP1255850B1 Amplification of cyp24 and uses thereof |
| 12/31/2008 | EP1218001B1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 12/31/2008 | EP1165127B1 Multivalent dengue virus vaccine |
| 12/31/2008 | EP1113810B1 Methods of treating multiple myeloma and myeloma-induced bone resorption using antagonists of integrin / receptor binding |
| 12/31/2008 | EP1102588B1 Pharmaceutical compositions for the prevention and treatment of central nervous system disorders comprising a nicotine analog and an acetylcholinesterase inhibitor |
| 12/31/2008 | EP0968716B1 Drugs for ameliorating ocular circulatory disorders |
| 12/31/2008 | CN101336113A Pharmaceutical comprising PPAR agonist |
| 12/31/2008 | CN101334356A Gas sensors |
| 12/31/2008 | CN101333196A 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 12/31/2008 | CN101332311A Drug-loaded mesh grid with slow-release function, production method and use thereof |
| 12/31/2008 | CN101332303A Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 12/31/2008 | CN101332302A Formula for preparing anti-eczema and cutitis products and preparation method thereof |
| 12/31/2008 | CN101332301A Antineoplastic composition and use thereof |
| 12/31/2008 | CN100447151C Peptide boronic acids useful in making salts thereof |
| 12/31/2008 | CN100446809C Injectable depot composition |
| 12/31/2008 | CN100446763C Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin |
| 12/31/2008 | CA2696961A1 Treatment of heart failure in non-human animal mammals by an aldosterone antagonist |
| 12/31/2008 | CA2692341A1 Use of a synergistic composition as a therapeutic agent or disinfectant |
| 12/31/2008 | CA2692282A1 Regulatory t cells in adipose tissue |
| 12/31/2008 | CA2691520A1 Composition for ophthalmic disease associated with hypoxia or ischemia |
| 12/31/2008 | CA2691054A1 Combinations of sap depleting agents and anti-sap antibodies |
| 12/31/2008 | CA2691005A1 Compositions comprising tryptophan hydroxylase inhibitors |
| 12/31/2008 | CA2689350A1 Treatment of depression |
| 12/31/2008 | CA2689299A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/30/2008 | US7470797 Nuclear hormone receptor modulator; anticarcinogenic agent; 3-(4-Cyano-3-trifluoromethylphenylcarbamoyl containing 3-carboxy-14-dimethyl-5-oxa-7-oxybicyclo(2.2.2) heptane compound |
| 12/30/2008 | US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 12/30/2008 | US7470720 Antiproliferative agents; synergistic mixture of anticarcinogenic agents with antiemetic |
| 12/30/2008 | US7470718 Administering formulation selected from calcium-channel blocker; a combination of a calcium-channel blocker and glutamate inhibitor; a combination of a calcium-channel blocker and hypertensive agent or mixtures |
| 12/30/2008 | US7470674 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides |
| 12/30/2008 | US7470663 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 12/30/2008 | US7470538 Introducing enriched human endothelial generating cells and mesenchymal stem cells; enhancing vasculogenesis and collateralization around blocked and/or narrowed vessels |
| 12/30/2008 | US7470428 Compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/30/2008 | CA2391497C Use of 5ht3 agonists for relaxing the fundus |
| 12/30/2008 | CA2353048C Pharmaceutical composition useful in the prevention or treatment of peptic ulcers |
| 12/30/2008 | CA2299423C Taste-masked pharmaceutical composition |